πŸ‡ΊπŸ‡Έ FDA
Patent

US 10835503

Pre-filled syringe

granted A61KA61K31/137A61K47/02

Quick answer

US patent 10835503 (Pre-filled syringe) held by Teva Pharmaceuticals USA, Inc. expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Pharmaceuticals USA, Inc.
Grant date
Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/137, A61K47/02, A61K47/12, A61K9/0019